Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

Clinical trial NCT06494397 · COMPLETED

Trial details

NCT number: NCT06494397
Sponsor: Vanda Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Bipolar I Disorder

Start date: 2024-07-11
Primary completion: 2024-10-24
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.